'The editorial did not beat around the bush. After decades of "expanding opioid use by minimizing the dangers of addiction," Pharma will now receive the reward of taxpayer money to undo what it did andreverse the opioid epidemic, writes the New York Times. Imagine the government giving Big Tobacco our tax dollars to reverse the damage it did pushing cigarettes and you see how obscene this is.
The new public-private partnership between Pharma and the NIH (and supported by both the FDA and DEA) will explore ways to address the opioid crisis such as "nonaddictive painkillers and new treatments for addiction and overdoses."
Not surprisingly, Pharma likes its reward. J. David Haddox, vice president for policy at Purdue Pharma (who makes OxyContin) appreciates the idea of “converting” the opioid market to abuse-deterrent drugs.
But the CEOs of Pharma's lobby group, Pharmaceutical Research and Manufacturers of America or PhRMA, and Purdue Pharma do not appreciate the Times' charges.
There is no reason Pharma shouldn't be involved in "the long-term solutions" for the opioid crisis writes PhRMA CEO Stephen Ubl, calling Pharma operatives "the best minds in science," in a letter to the Times. Craig Landau, CEO of Purdue, appreciates the "regulatory framework to incentivize" Pharma to develop post opioid crisis drugs and writes that Pharma cannot "abandon... pain patients," in a letter to the Times.'
Read more: Funding Big Pharma to Help with Millions of Addicts They Created
Did you like this article?
Thank you for your vote!
2 July 2018
MEDICAL TYRANNY: Doctors ordered to refuse health care services to parents who opt out of child vaccinations
1 July 2018
Amazon to become your Big Pharma drug dealer: Purchases online pharmacy for nearly $1 billion
30 June 2018
Trump’s DOJ criminally charges 76 doctors, 23 pharmacists, 19 nurses raking in billions in medical fraud to push toxic drugs
From our advertisers
4 hours ago
Brexit referendum must be 're-run' after Vote Leave fined for spending breaches, say MPs
From our advertisers